INS and metabolic syndrome: CCL4 inhibition mice also had decreased levels of phosphorylated IRS-1 in both skeletal muscle and liver tissues compared to those in the untreated metabolic syndrome mice (Figures 4I, J), implying the beneficial effects of CCL4 inhibition on insulin signaling.